Literature DB >> 31085142

The uses and expenses of antihypertensive medications among hypertensive adults.

Chanhyun Park1, Guijing Wang2, Boon Peng Ng3, Jing Fang2, Jeffrey M Durthaler2, Carma Ayala2.   

Abstract

BACKGROUND: The literature lacks information about the use and cost of prescribed antihypertensive medications, especially by the type and class of medication prescribed.
OBJECTIVE: This study investigated the uses and expenses of antihypertensive medications among hypertensive adults in the United States.
METHODS: Using the 2014-2015 Medical Expenditure Panel Survey data, adult men and nonpregnant women aged 18 or older who had a diagnosis code of hypertension and used any prescribed antihypertensive medication were included in the study (n = 10,971). Adults with hypertension who were using a single antihypertensive medication were defined as single medication users, and those using two or more medications were defined as multiple medication users. Medications were classified into angiotensin-converting-enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), calcium channel blockers (CCBs), thiazide-type diuretics (TDs), β-blockers (BBs), and others. The average annual total antihypertensive medication expenses and the expenditures of each medication class were estimated by using generalized linear models with a log link and gamma distribution and were adjusted to 2015 US dollars.
RESULTS: Among 10,971 hypertensive adults, 4759 (44.1%) were single medication users, and 6212 (55.9%) were multiple medication users. The average annual total cost for antihypertensive medications was $336 per person (95% confidence interval [CI] = $319-$353); $199 (95% CI = $177-$221) for single medication users and $436 (95% CI = $413-$459) for multiple medication users. The average annual costs for each medication class were estimated at $438 (95% CI = $384-$492) for ARBs and $49 for TDs (95% CI = $44-$55).
CONCLUSIONS: Users of multiple medications incurred more than twice the expense than single medication users. When comparing classes of medications, the cost for ARBs was the highest, whereas the cost for TDs was the lowest. This information can be used in evaluating the cost-effectiveness of antihypertension therapies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug class; High blood pressure; Hypertension; Medication expenses

Mesh:

Substances:

Year:  2019        PMID: 31085142     DOI: 10.1016/j.sapharm.2019.05.002

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  4 in total

1.  Antihypertensive Use and the Risk of Alzheimer's Disease and Related Dementias among Older Adults in the USA.

Authors:  Xi Pan; Donglan Zhang; Ji Haeng Heo; Chanhyun Park; Gang Li; Christine M Dengler-Crish; Yan Li; Yian Gu; Henry N Young; Devin L Lavender; Lu Shi
Journal:  Drugs Aging       Date:  2022-10-17       Impact factor: 4.271

2.  Starting Antihypertensive Drug Treatment With Combination Therapy: Controversies in Hypertension - Con Side of the Argument.

Authors:  Zhen-Yu Zhang; Yu-Ling Yu; Kei Asayama; Tine W Hansen; Gladys E Maestre; Jan A Staessen
Journal:  Hypertension       Date:  2021-02-10       Impact factor: 10.190

3.  Risk of Hypertension and Use of Antihypertensive Drugs in the Physically Active Population under-70 Years Old-Spanish Health Survey.

Authors:  Ángel Denche-Zamorano; Jorge Pérez-Gómez; Maria Mendoza-Muñoz; Jorge Carlos-Vivas; Rafael Oliveira; João Paulo Brito
Journal:  Healthcare (Basel)       Date:  2022-07-11

4.  The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?

Authors:  Hatouf H Sukkarieh; Rami T Bustami; Manasik N Abdu; Ayesha A Khokhar; Amir A Salih; Hana K Abdalla
Journal:  Saudi Med J       Date:  2020-10       Impact factor: 1.484

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.